🚨 JUST IN: $CMPX
FDA tells Compass to run survival trial before BLA for tovecimig; company disagrees

#SEC #stocks #investing #CMPX #Regulatory
🔗 secwatch.observer

#CMPX Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback

https://www.stocktitan.net/news/CMPX/compass-therapeutics-provides-regulatory-update-on-tovecimig-in-yfx5q0vg64h6.html?utm_source=stocktitan-bluesky&utm_medium=social